Abstract
Malignant brain tumours are known to have a faster rate of recurrence and increased resistance to radiotherapy and chemotherapy than other solid tumours.1 One of the related causes is thought to be focal hypoxia,2 however the presence of hypoxic areas in malignant brain tumours has been disputed by PET studies and by the marginal effect of the hypoxic cell sensitisers such as Misonidazole.3 Low pO2 areas (<2.5mmHg) provide a source of radiobiological resistance,4 whereas pO2 levers less than 10–15 mmHg may provide conditions for the activation of new classes ofbioreductive agents.5 These agents require metabolic reduction under conditions of low oxygen tension to generate a cytotoxic species. In this study the oxygen status of peritumoural brain and tumour tissue has been measured to determine the presence of hypoxic regions and conditions for drug activation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bloom H.J.G. Intracranial tumours: Response and resistance to therapeutic endeavours 1970–1980. Int.J. Radiation Oncol. Biol. Phys. 8:1083–1113, 1982
Gray L.H, Conger A.D, Ebert M, Hornsey S, Scott O.C.A. Concentration of oxygen dissolved in tissues at time of irradiation as a factor in Radiotherapy. Br.J.Radiol 26:638–648,1953
Brooks D.J, Beaney R.P, Thomas D.G. The role of Positron Emission Tomography in the study of Cerebral Tumours. Seminars in Oncology, 13:83–93, 1986
Bush R.S, Jenkin R.D.T, Allt W.E.C, Beale F.A, Bean H, Dembo A.J, Pringle J.F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br.J.Cancer, 37(Supp1.3):302–306, 1978
Workman P, Walton M.I. Enzyme-directed bioreductive drug development. In:Adams E, Breccia A, Fielden E, Wardman P. eds: Selective activation of drugs by Redox processes. New York, NY:Plenum;1991:173–191
Schultheiss R, Leuwer R, Leniger-Follert E, Wassmann H, Wullenweber R. Tissue pO2 of Human Brain Cortex-Method, Basic Results and Effects of Pentoxifylline Angiology 38: 3 221–225.
Grote J. In: Schmidt R.F, Thews G. eds. Physiologie des Menschen. Springer,Berlin 23 ed: p635
Fleckenstein W, Schaffler A, Heinrich R, Petersen M, Gunderoth-Palmowski M Nollert G. On the Differences between Muscle pO2 measurements obtained with Hypodermic Needle Probes and with Multiwire Surface Probes. Parts 1 & 2, In: Clinical Oxygen Pressure Measurement II eds: Ehrly A.M, Fleckenstein W, Hauss J, H Huch R. Blackwell Ueberreuter Wissenschaft. Berlin, 1990
Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of Human Tumours: Evaluation of Tissue Oxygen Distribution in Breast Cancers by Computerised O2Tension Measurements. Cancer Research 51:3316–3322, 1991
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cruickshank, G.S., Rampling, R.P., Cowans, W. (1994). Direct Measurement of the PO2 Distribution in Human Malignant Brain Tumours. In: Vaupel, P., Zander, R., Bruley, D.F. (eds) Oxygen Transport to Tissue XV. Advances in Experimental Medicine and Biology, vol 345. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2468-7_62
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2468-7_62
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6051-3
Online ISBN: 978-1-4615-2468-7
eBook Packages: Springer Book Archive